ArticleCellular and molecular life sciences : CMLS2024

EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells.

Jasmin Huttunen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.